MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
vmhM:thcrm_hs vmhM:thcrm_hs vmhmetabolite:thcrm_hs vmhmetabolite:thcrm_hs HJVQASFQICDJJP-AARKWTLXSA-N | Trihexosyl ceramide Bassen-kornzweig syndrome Cell signaling agent Cellular membrane Ceramide trihexoside D-Galactosyl-1,4-D-galactosyl-1,4-D-glucosylceramide Dietary supplement Digestion Extracellular region Fabry glycolipid Fauna Gal-alpha1->4gal-beta1->4GLC-beta1->1'cer Gal-alpha1->4laccer Ganglioside GL3 Gb3 Globo-N-triaosylceramide Globotriaosylceramide Globotriglycosylceramide Globotriosylceramide Kidneys Lipid metabolic process Membrane integrity agent Membrane stability agent N-[(2S,3R,4E)-1-{[(2R,3R,4R,5S,6R)-5-{[(2S,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]dodecanimidate Neuron Nutraceutical Shiga toxin receptor Signal transduction Signaling agent Signalling molecule Surface-active agent delta-Galactosyl-1,4-delta-galactosyl-1,4-delta-glucosylceramide |
vmhM:M_thcrm_hs | secondary/obsolete/fantasy identifier |